Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ESALF

Recent news which mentions ESALF

< Previous 1 2 Next >
Biogen's Alzheimer's Drug Secures UK Approval, But An Independent Agency Does Not Recommend Reimbursement
Tickers BIIB ESAIY ESALF NEWS
Tags Health Care ESALF Top Stories
From Benzinga
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
Tickers BIIB ESALF ESALY LLY
Tags Stories That Matter Benzinga ESALY
From Benzinga
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
Tickers BIIB BMY ESALF JNJ
Tags Benzinga healthcare Sanders
From Benzinga
Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibodies: Analyst
Tickers BIIB ESAIY ESALF LLY
Tags Benzinga Stories That Matter Movers
From Benzinga
Why Is Eli Lilly Stock Trading Higher Premarket Tuesday?
Tickers BIIB ESALF LLY NEWS
Tags News Equities ESALF
From Benzinga
European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug Lecanemab
Tickers BIIB ESALF ESALY NEWS
Tags ESALF Health Care News
From Benzinga
Merck, Eisai Report Yet Another Failure For Keytruda Plus Lenvima Combo Trial, This Time In Endometrial Cancer
Tickers ESALF ESALY MRK
Tags MRK General Market News
From Benzinga
Biogen quarterly results top estimates despite complex launch of new Alzheimer’s treatment
Tickers BIIB ESALF SPX
Tags SPX ESALF BIIB
From MarketWatch
Eli Lilly chief scientific officer ‘extremely optimistic’ that major new Alzheimer’s breakthrough is coming
Tickers BIIB ESALF JNJ LLY
Tags MRK BIIB PFE
From MarketWatch
Eli Lilly’s stock rises as results beat expectations, Mounjaro sales surge
Tickers BIIB ESALF LLY SPX
Tags BIIB ESALF LLY
From MarketWatch
Biogen and Eisai release new Alzheimer’s drug data that may support wider uptake
Tickers BIIB ESALF LLY
Tags ESALF LLY BIIB
From MarketWatch
Improved Alzheimer's Diagnosis Access: CMS Expands Amyloid PET Scan Usage
Tickers BIIB ESALF ESALY LLY
Tags Briefs Government ESALY
From Benzinga
LuMind CEO At Odds With Neurologists Over Alzheimer's Drugs Made By Biogen, Eli Lilly
Tickers BIIB ESALF ESALY LLY
Tags Benzinga ESALY Biotech
From Benzinga
Amazon Invests $4B In ChatGPT Competitor, Hollywood Writers Accept Tentative Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories
Tickers AA AAPL AMZN BIIB
Tags F Benzinga PFE
From Benzinga
Japan's Regulatory Authority Approves Biogen/Eisai's Alzheimer Treatment Leqembi
Tickers BIIB ESALF ESALY
Tags ESALF Benzinga Health Care
From Benzinga
Merck-Eisai Partnered Two Keytruda/Lenvima Combo Trials Flunk In Certain Types Of Lung Cancer
Tickers ESALF ESALY MRK
Tags Large Cap Briefs News
From Benzinga
Merck/Eisai's Cancer Combo Therapy Ambition Dashed Once Again, Companies Throw Towel On Head & Neck Trial
Tickers ESALF ESALY MRK
Tags Large Cap Briefs News
From Benzinga
Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer’s disease
Tickers BIIB DGX ESALF LLY
Tags LLY SPX ESALF
From MarketWatch
Biogen to slash 1,000 jobs as it looks to save $700 million
Tickers BIIB ESALF LLY SAGE
Tags BIIB SAGE ESALF
From MarketWatch
At-home Alzheimer’s testing is on the horizon, researchers say
Tickers BIIB ESALF LLY
Tags BIIB ESALF LLY
From MarketWatch
Eli Lilly’s Alzheimer’s treatment shows promise in early stages of disease — but safety concerns remain
Tickers BIIB ESALF LLY SPX
Tags SPX LLY ESALF
From MarketWatch
Expanded Medicare Coverage For Biogen-Eisai's Leqembi Signals a Turning Point in Alzheimer's Treatment: Analysts
Tickers BIIB ESALF ESALY
Tags Biotech ESALY Benzinga
From Benzinga
Biogen’s big Alzheimer’s drug win fails to boost the stock as analysts see slow Leqembi rollout
Tickers BIIB ESALF LLY
Tags BIIB ESALF LLY
From MarketWatch
FDA approves Alzheimer’s treatment Leqembi, clearing the way for Medicare coverage
Tickers BIIB ESALF LLY
Tags BIIB LLY ESALF
From MarketWatch
Alzheimer's Drug Leqembi Faces Hurdles in Europe: Concerns Over Health Risks and Healthcare Resources
Tickers BIIB ESALF ESALY
Tags General Briefs ESALY
From Benzinga
Prospects for Full Approval of Eisai and Biogen's Leqembi Shine Brighter after FDA Committee Vote
Tickers BIIB ESALF ESALY
Tags News Large Cap Trading Ideas
From Benzinga
Goldman pushes back against bearish Morgan Stanley’s Mike Wilson with new 4,500 S&P 500 target
Tickers AAPL AMC AMD AMZN
Tags ORCL SPX AMC
From MarketWatch
Biogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the move
Tickers BIIB CCF CVNA ESALF
Tags BIIB CCF CA:TECK/B
From MarketWatch
FDA advisers vote in favor of Biogen and Eisai’s collaborative Alzheimer’s treatment
Tickers BIIB ESALF
Tags BIIB ESALF
From MarketWatch
Bernie Sanders Takes on High Costs of Alzheimer's Treatment Leqembi, Calls Price Tag 'Unconscionable'
Tickers BIIB ESALF ESALY
Tags BIIB Market News News
From Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.